Cell / Gene Therapy

((SLA-025)) (SLA-025) Second Primary Malignancy in Patients with Diffuse Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy and Other Systemic Anti-Cancer Therapy: A Real-World Evidence from a Large US National Claims Database

((SLA-026)) (SLA-026) Comparative Effectiveness of Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma: An External Control Arm Study Using Lymphoma Registry